Cyanotech Corporation (CYAN) Stock
Established in 1983 and headquartered in Kailua-Kona, Hawaii, Cyanotech Corporation specializes in the global cultivation, processing, and distribution of natural products derived from microalgae. Its key product offerings include BioAstin Hawaiian Astaxanthin, a powerful dietary antioxidant acclaimed for promoting skin health and supporting eye, joint, and immune system functions; it is utilized as both a dietary supplement and an ingredient.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Cyanotech Corporation
Established in 1983 and headquartered in Kailua-Kona, Hawaii, Cyanotech Corporation specializes in the global cultivation, processing, and distribution of natural products derived from microalgae. Its key product offerings include BioAstin Hawaiian Astaxanthin, a powerful dietary antioxidant acclaimed for promoting skin health and supporting eye, joint, and immune system functions; it is utilized as both a dietary supplement and an ingredient. Another significant product is Hawaiian Spirulina Pacifica, a highly nutritious dietary supplement formulated to enhance energy levels, bolster the immune system, provide cardiovascular benefits, and deliver a rich source of antioxidant carotenoids. Beyond its product lines, Cyanotech also offers contract extraction services. The company reaches its customers through a diverse array of sales channels, encompassing third-party distributors, retailers, and online platforms, as well as direct sales to consumers. Additionally, it supplies products in bulk to manufacturers, formulators, and distributors within the health foods, nutraceuticals, and dietary supplement industries.
Cyanotech Corporation is headquartered in US.
Cyanotech Corporation (CYAN) stock trades at $0.53 with a market capitalization of $3.92M. The stock is valued at a price-to-earnings (P/E) ratio of -2.97, price-to-book of 0.50, price-to-sales of 0.15. Over the past 52 weeks the stock has ranged between $0.21 and $0.57, and currently trades 7.0% below its 52-week high.
On profitability, Cyanotech Corporation generates a return on equity (ROE) of -16.26%, return on capital employed of -5.12%, an operating margin of -2.20%, a net profit margin of -4.83%.
Official website: www.cyanotech.com